Encore Pharmaceuticals Inc.

United States: Denbury Acquires Encore for $4.5 B; Ford Surges.
TendersInfo; 11/4/2009; 1192 words; ...Resources agreed to acquire Encore Acquisition Corp for...Denbury Resources Inc led the decliners in...in Office Depot, Inc of 4.1%, in Moody...Varian Medical Systems, Inc 6.4%, in Tenet Healthcare...a year ago. Amylin Pharmaceuticals, Inc (AMLN) surged...and Japan based Takeda ...

Zacks #5 Rank Additions for Tuesday - Zacks Tale of the Tape
Zacks Investment Research - Zacks Tale of the Tape; 11/3/2009; 453 words; ...International Inc ( ) Dixie Group Inc ( ) Encore Energy Partners LP ( ) Farmers Capital...Holdings Inc ( ) Southwest Bancorp Inc ( ) SPX Corp ( ) St Jude Medical Inc ( ) Stanley Furniture Co Inc ( ) Sucampo Pharmaceuticals Inc ( ) Sun Microsystems Inc...

Other News To Note.
BIOWORLD Today; 11/3/2009; 3196 words; ...terms were not disclosed. DOV Pharmaceutical Inc., of Hackensack, N.J...based Merck & Co. Inc. for clinical development...following testing by Merck. Encore Pharmaceuticals Inc., of Riverside, Calif...

'Extensive' Bidding War Ends With Pfizer Taking Over Rinat.
BIOWORLD Today; 11/3/2009; 1092 words; ...long respite, Pfizer Inc. is throwing money...some of the biggest pharmaceutical companies in the world...to take over Vicuron Pharmaceuticals Inc., of King of Prussia...Idun Pharmaceuticals Inc. for an undisclosed...in December 2000 from Encore Pharmaceuticals ...

Elan to Highlight Tysabri Data in Crohn's Disease at the American College of Gastroenterology Annual Scientific Meeting.
Clinical Trials Week; 11/2/2009; 906 words; ...Natalizumab as Continuous Therapy] and ENCORE [Efficacy of Natalizumab in Crohn...surveillance program. Keywords: , Health, Pharmaceutical, Other Health, Biogen Idec Inc., Biotechnology, Biotechnology Business...Monoclonal Antibodies, Natalizumab, Pharmaceuticals, Therapy, Treatment, Tysabri, ...